Literature DB >> 25887445

Early improvement in serial echocardiographic studies in heart failure patients predicts long term survival-a pilot study.

Karima Addetia1, Caroline Michel2, Christina A Holcroft3, Richard Sheppard2, Lawrence G Rudski4.   

Abstract

BACKGROUND: Several echocardiographic measures have prognostic value in heart failure (HF). However, no definitive data exist on how changes in these parameters with treatment affect survival in this patient population. We hypothesized that early improvement on echocardiography could predict long-term survival. METHODS AND
RESULTS: We conducted a retrospective review of 404 patients seen in the HF clinic from 2002 to 2008 (6.5 years). Patients had one echocardiogram ≤1 year before and another ≥1 month (10 ± 7 months) after treatment onset. We studied changes in standard echocardiographic parameters, including left (LV) and right (RV) ventricular size and/or function (systolic and/or diastolic), valvular (mitral and tricuspid) function, and pulmonary artery pressure. Survival curves and hazard ratios were generated for patients showing improvement on the 2nd echocardiogram versus those who did not. Multivariable analyses were performed adjusting for age, sex, ischemic etiology, and significant baseline echocardiographic parameters. Average follow-up was 2.9 ± 1.5 years. Improvement in LV end-systolic dimension, RV function, and mitral regurgitation were independent predictors of 5-year survival (P < .05) and, importantly, more predictive than baseline values of these parameters alone (higher hazard ratios).
CONCLUSIONS: Early echocardiographic improvement is strongly associated with 5-year survival in patients with HF. Serial echocardiography may aid in stratifying patient care.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; echocardiography; prognosis; survival

Mesh:

Year:  2015        PMID: 25887445     DOI: 10.1016/j.cardfail.2015.04.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  1 in total

1.  BNP as a marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer.

Authors:  Xiang Lu; Yingying Zhao; Caiping Chen; Chao Han; Li Xue; Dan Xing; Ou Huang; Min Tao
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.